Updated:
Ontario Bioscience Innovation Organization
Ontario Bioscience Innovation Organization (OBIO) is a not-for-profit organization founded in 2009 in Toronto, Canada. It focuses on the life sciences and...
Ontario Bioscience Innovation Organization
Ontario Bioscience Innovation Organization (OBIO) is a not-for-profit organization founded in 2009 in Toronto, Canada. It focuses on the life sciences and health technology sectors, providing support for early-stage and venture-backed companies. Services include capital raising, workforce development, technology commercialization, mentorship, and access to grants and resources.
General information
Firm type
other
Location
Region
North America
Country
Canada
City
Toronto
Corporate office
Toronto, ON, Canada
Additional offices
Montreal, QC, Canada · La Jolla, CA, United States
Sector focus
Frequently asked questions
How is OBIO structured, and does it operate a direct investment program?
OBIO is a not-for-profit industry association with a hybrid structure. It manages the OBIO Investment Fund, which makes direct equity investments in early-stage Ontario health-science companies. The fund is backed by the Government of Ontario and private-sector contributors.
Which types of companies does the OBIO Investment Fund target?
The fund targets pre-revenue and early-stage Ontario-based companies developing therapeutics, medical devices, diagnostics, and digital health technologies. It fills a critical capital gap between angel funding and later-stage venture capital for capital-intensive life-science startups.
Does OBIO work exclusively in Ontario, or does it have cross-border activity?
OBIO's mandate is centered on Ontario, but its operations are explicitly cross-border. It maintains an office in La Jolla, California, to create deal-flow and partnership bridges between Ontario companies and US-based investors and life-science corporate partners.
What is OBIO's role beyond that of a typical industry trade association?
Beyond advocacy, OBIO directly addresses two structural bottlenecks for life-science firms: talent and capital. It runs a large-scale internship program that places graduate-level talent into biotech startups, and it manages a direct-investment seed fund — functions that make it an active ecosystem builder rather than just a membership body.
How does OBIO source its investment pipeline?
OBIO sources its investment pipeline through deep ties to Ontario's research universities, teaching hospitals, and its annual investment summit. The summit screens and showcases vetted Ontario health-science companies to a curated audience of global institutional investors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: